Hennion & Walsh Asset Management’s AstraZeneca AZN Stock Holding History

Hennion & Walsh Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,093	Closed	-$283K	–	776
2022 Q4	$283K	Buy	+2,093	New	+$262K	0.02%	647
2022 Q3	–	Sell	-1,932	Closed	-$255K	–	767
2022 Q2	$255K	Sell	1,932 -340	-15%	-$44.6K	0.02%	668
2022 Q1	$301K	Buy	2,272 +147	+7%	+$17.6K	0.02%	655
2021 Q4	$247K	Sell	2,125 -575	-21%	-$67.7K	0.01%	677
2021 Q3	$324K	Sell	2,700 -6,808	-72%	-$792K	0.02%	618
2021 Q2	$1.14M	Sell	9,508 -482	-5%	-$52.9K	0.06%	335
2021 Q1	$993K	Buy	+9,990	New	+$1M	0.06%	356

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hennion & Walsh Asset Management's AZN Position: Q1 2023 in Review

Hennion & Walsh Asset Management sold out of AstraZeneca (AZN) in Q1 2023, closing a stake of 2,093 shares — an estimated $283K sold.

Hennion & Walsh Asset Management first reported a position in AZN in Q1 2021 and held it in 7 quarters. The position peaked at $1.14M in Q2 2021. 1,054 funds tracked by Wall St. Rank hold AZN as of Q1 2023.

Hennion & Walsh Asset Management reported no remaining AstraZeneca position as of Q1 2023 after selling out during the quarter.
Hennion & Walsh Asset Management sold 2,093 AstraZeneca shares in Q1 2023, an estimated $283K.
Hennion & Walsh Asset Management first reported a position in AstraZeneca in Q1 2021 and held it in 7 quarters.
Hennion & Walsh Asset Management's AstraZeneca position peaked at $1.14M in Q2 2021.
1,054 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2023, filed 20 Apr 2023.